Dexcom Launches First OTC Glucose Monitor in U.S.

Aug 26, 2024, 10:06 AM

Dexcom has launched Stelo, the first over-the-counter continuous glucose monitor (CGM) in the United States. The device, announced earlier this year at CES 2024, aims to provide a more affordable option for people with Type 2 diabetes to access CGMs. The availability of Stelo marks a significant step in the fight against diabetes by improving accessibility to essential monitoring technology.